{
  "url": "https://www.law.cornell.edu/regulations/new-york/N-Y-Comp-Codes-R--Regs-Tit-8-SS-64.7",
  "title": "N.Y. Comp. Codes R. & Regs. Tit. 8 ยง 64.7 - [Effective 7/10/2025] Provision of certain medical services pursuant to non-patient specific orders and protocols",
  "content": "N.Y. Comp. Codes R. & Regs. Tit. 8 ยง 64.7 - [Effective 7/10/2025] Provision of certain medical services pursuant to non-patient specific orders and protocols\n\nState Regulations\n(a) Immunizations. (1)\n\nAs used in this\nsubdivision: (i) Immunizing\nagents\nmeans vaccines and immunoglobulin drugs approved by the federal\n\nFood and Drug Administration to provide immunity against diseases caused by the\ninfectious agents described in clauses\n(a) through\n(e) of this subparagraph. (a) In the case of adults, vaccines against\nthe following infectious diseases: Hepatitis A, Hepatitis B, Influenza, Pneumococcus, Diphtheria, Tetanus, Measles, Mumps, Rubella, Varicella, Polio, Pertussis, Human Papilloma Virus, Meningococcus, Respiratory Syncytial Virus, and Herpes Zoster; (b) In the case\nof infants and children under the age of 18, vaccines against the following\ninfectious diseases: Diphtheria, Tetanus, Pertussis, Measles, Mumps, Rubella, Varicella, Haemophilus Influenzae Type b (Hib), Polio, Hepatitis B, Hepatitis\nA, Influenza, Meningococcus, Pneumococcus, Rotavirus, Respiratory Syncytial\n\nVirus, and Human Papilloma Virus; (c) immunizing agents against an infectious\ndisease that causes an epidemic or a community wide outbreak, provided that\nsuch immunizing agents are administered as part of a public health program\nestablished by the Commissioner of the Department of Health, a County\n\nCommissioner of Health, or a County Public Health Director to immunize persons\nagainst the infectious disease during the epidemic or community outbreak of the\ninfectious disease; (d) additional\nimmunizing agents approved by resolution of the Board of Regents upon\nrecommendation by the commissioner that such additional immunization agents are\nsafe and effective immunization agents for registered professional nurses to\nadminister to patients, pursuant to a non-patient specific order and protocol\nas prescribed in this section, after consideration of the recommendations of\n\nState and/or nationwide authorities that evaluate the effectiveness and safety\nof immunization agents, including but not limited to the Centers for Disease\n\nControl and Prevention of the U.S. Department of Health and Human Services. Such additional immunization agents, which are not specifically enumerated in\nthis subparagraph, may be removed by resolution of the Board of Regents, upon\nrecommendation of the commissioner that such immunization agents are not safe\nand effective immunization agents for registered professional nurses to\nadminister to patients, pursuant to a non-patient specific order and protocol\nas prescribed in this section, after consideration of the recommendations of\n\nState and/or nationwide authorities that evaluate the effectiveness and safety\nof immunization agents, including but not limited to the Centers for Disease\n\nControl and Prevention of the U.S. Department of Health and Human Services; and\n(e) vaccines that are fully\napproved or authorized for emergency use by the federal Food and Drug\n\nAdministration to provide immunity against COVID-19 and administered in\naccordance with applicable federal Food and Drug Administration requirements\nand recommendations. (ii)\n\nEntity\nmeans a State or local government, partnership, corporation or other legal entity that is authorized by the Public Health Law, Education Law or other State statute to provide professional nursing\nservices. (2)\nA\nregistered professional nurse may administer immunizing agent(s) pursuant to a\nwritten non-patient specific order and protocol prescribed or ordered by a\nlicensed physician or a certified nurse practitioner, provided that the\nrequirements of this subdivision are met. (i) The registered professional nurse shall be certified in cardio-pulmonary\nresuscitation or basic life support by the American Red Cross, the American\n\nHeart Association or an equivalent organization acceptable to the department\nwhich has an established record of providing programs of cardio-pulmonary\nresuscitation training. (ii)\n\nThe\nregistered professional nurse shall ensure that anaphylactic agents, syringes\nand needles are available at the location where the immunizing agents are being\nadministered. (3)\n\nOrder\nand protocol. (i) The non-patient specific\norder shall include, at a minimum, the following: (a) the name, license number and signature of\nthe licensed physician or certified nurse practitioner who orders or prescribes\nthe non-patient specific order and protocol; (b) the name of the specific immunizing\nagent(s) to be administered; (c) a\nprotocol for administering the ordered immunizing agent(s) or a specific\nreference to a separate written protocol for administering the ordered\nimmunizing agent(s), which shall meet the requirements of subparagraph (ii) of\nthis paragraph; (d) the period of\ntime that the order is effective, including the beginning and ending\ndates; (e) a description of the\ngroup(s) of persons to be immunized, including the age range of such\npersons; (f) the name and license\nnumber of the registered professional nurse(s) authorized to execute the\nnon-patient specific order and protocol to administer the immunizing agent(s); or the name of the entity that employs or contracts with registered\nprofessional nurses to execute the non-patient specific order and protocol, provided that the registered professional nurse(s) execute the non-patient\nspecific order and protocol only in the course of such employment or pursuant\nto such contract and provided further that the entity is legally authorized to\nemploy or contract with registered professional nurses to provide nursing\nservices. (ii)\n\nThe\nwritten protocol, incorporated into the order prescribed in subparagraph (i) of\nthis paragraph, shall, at a minimum, require the registered professional\nnurse(s) to ensure that: (a) each potential\nrecipient is assessed, pursuant to criteria in the protocol, for conditions\nthat would qualify or preclude him or her from receiving the ordered immunizing\nagent(s); (b) the potential\nrecipient, or when the potential recipient lacks capacity to consent, a person\nauthorized pursuant to law to consent to health care for the potential\nrecipient, receives federally required vaccine information, such as vaccine\ninformation statements, if applicable, and instructions on addressing adverse\nreactions to the vaccine; (c) informed consent for administering the ordered immunizing agent(s) has been\nobtained, pursuant to the criteria in the protocol, from the recipient, or when\nthe recipient lacks capacity to consent, a person authorized pursuant to law to\nconsent to health care for the recipient; (d) the administration of the ordered\nimmunizing agent(s) is documented, including the recipient's name, date of\nadministration, address of administration, administering nurse, immunization\nagent(s), manufacturer(s), lot number(s), in accordance with criteria in the\nprotocol and that documentation relating to the immunizing agent(s) is\nmaintained in accordance with section\n29.2\n(a)(3)\nof this\n\nTitle; (e) the recipient, or when\nthe recipient lacks capacity to consent, a person authorized pursuant to law to\nconsent to health care for the recipient, receives a certificate of\nimmunization with the recipient's name, date of administration, address of\nadministration, administering nurse, immunization agent(s), manufacturer(s), and lot number(s). With the consent of the recipient or a person authorized to\nconsent for the recipient, the registered professional nurse shall communicate\nthis information to the recipient's primary health care provider; (f) adverse outcomes resulting from the\nadministered immunizing agent(s) shall be reported to the United States\n\nDepartment of Health and Human Services, as may be required by Federal Law; and\n(g) immunizing agents\nadministered to recipients are reported to the Department of Health or the New\n\nYork City Department of Health and Mental Hygiene, as may be required by\nlaw. (b) Anaphylaxis treatment agents. (1)\n\nPursuant to section\n6909\n(5)\nthe Education Law, a registered\nprofessional nurse shall be authorized to administer anaphylaxis treatment\nagents, including but not limited to epinephrine, for the emergency treatment\nof anaphylaxis, pursuant to a non-patient specific order and protocol\nprescribed and ordered by a licensed physician or a certified nurse\npractitioner, provided the order and protocol meets the requirements of\nparagraph (2) this subdivision. (2)\n\nOrder and protocol. (i) The registered\nprofessional nurse shall either maintain or ensure the maintenance of a copy of\nthe non-patient specific order and protocol prescribed by a licensed physician\nor a certified nurse practitioner which authorizes a registered professional\nnurse to administer anaphylaxis treatment agents, including but not limited to\nepinephrine, for the emergency treatment of anaphylaxis, in accordance with the\nrequirements of paragraph (1) of this subdivision. The order prescribed in\nsubparagraph (ii) of this paragraph shall incorporate a protocol that meets the\nrequirements of subparagraph (iii) of this paragraph. Such order and protocol\nshall be considered a record of the patient who receives the anaphylaxis\ntreatment agent and maintained as a record for the period of time prescribed in\nsection\n29.2\n(a)(3)\nof this\n\nTitle. (ii)\n\nThe order shall\nauthorize one or more named registered professional nurses, or registered\nprofessional nurses who are not individually named but are identified as\nemployed or under contract with an entity that is legally authorized to employ\nor contract with registered professional nurses to provide nursing services, to\nadminister specified anaphylaxis treatment agents for a prescribed period of\ntime. In instances in which the registered professional nurses are not\nindividually named in the order, but are identified as employed or under\ncontract with an entity that is legally authorized to employ or contract with\nregistered professional nurses to provide nursing services, such registered\nprofessional nurses shall not be authorized by such order to administer\nanaphylaxis treatment agents outside of such employment or contract. The order\nshall contain but shall not be limited to the following information: (a) the specific anaphylaxis treatment agents\nthat the registered professional nurse(s) is permitted to administer; (b) the period of time that the order is\neffective, including the beginning and end date; (c) the name and license number of the\nregistered professional nurse(s) authorized to administer the anaphylaxis\ntreatment agent(s) pursuant to the order; or the name of the entity that is\nlegally authorized to employ or contract with registered professional nurses to\nprovide nursing services with whom registered professional nurses who are not\nindividually named are employed or under contract to administer the prescribed\nanaphylaxis treatment agent(s) pursuant to the order; (d) in instances in which the registered\nprofessional nurses are not individually named in the order, but are identified\nas employed or under contract with an entity that is legally authorized to\nemploy or contract with registered professional nurses to provide nursing\nservices, the order shall contain a statement limiting the registered\nprofessional nurses to administering anaphylaxis treatment agents only in the\ncourse of such employment or pursuant to such contract; and\n(e) the name, license number, and signature\nof the licensed physician or certified nurse practitioner who has issued the\norder. (iii)\n\nThe\nprotocol, incorporated into the order prescribed in subparagraph (ii) of this\nparagraph, shall require the registered professional nurse to meet the\nfollowing requirements: (a) Each registered\nprofessional nurse shall ensure that a record of all persons to whom they have\nadministered an anaphylaxis treatment agent, including but not limited to: the\nrecipient's name, date, address of administration, administering nurse, anaphylaxis treatment agent, manufacturer, and lot number, is recorded and\nmaintained in accordance with section\n29.2\n(a)(3)\nof this\n\nTitle. (b) The registered\nprofessional nurse shall contact the local emergency medical services system\nfollowing the administration of the anaphylaxis treatment agent, or shall\nensure that equivalent follow-up care is provided through other\narrangements. (c) The registered\nprofessional nurse shall report to the local emergency medical system or other\nprovider of equivalent follow-up care information concerning the administration\nof the anaphylaxis treatment agent, including but not limited to: when it was\nadministered, the dosage, strength, and route of administration. The registered\nprofessional nurse shall also report such information to the patient's primary\ncare provider if one exists, unless the patient is unable to communicate the\nidentity of his or her primary care\nprovider. (c) Tuberculosis tests. (1)\n\nAs used in this subdivision, tuberculosis tests\nmeans one or more laboratory or point of\ncare tests approved by the Federal Food and Drug Administration to detect or\nscreen for tuberculosis infections, including, but not limited to, tuberculin\nskin tests (purified protein derivative [PPD] tests). (2)\nA registered professional nurse may\nadminister tuberculosis tests pursuant to a written non-patient specific order\nand protocol prescribed or ordered by a licensed physician or a certified nurse\npractitioner, provided that the requirements of this subdivision are\nmet. (3)\n\nOrder and protocol. (i) The non-patient specific order shall\ninclude, at a minimum, the following: (a) the\nname, license number and signature of the licensed physician or certified nurse\npractitioner who orders or prescribes the non-patient specific order and\nprotocol; (b) the name of the\nspecific tuberculosis tests to be administered; (c) a protocol for administering the ordered\ntuberculosis tests or a specific reference to a separate written protocol for\nadministering the ordered tuberculosis tests, which shall meet the requirements\nof subparagraph (ii) of this paragraph; (d) the period of time that the order is\neffective, including the beginning and ending dates; (e) a description of the group(s) of persons\nto be treated; and\n(f) the name and\nlicense number of the registered professional nurse(s) authorized to execute\nthe non-patient specific order and protocol to administer the tuberculosis\ntests; or the name of the entity that employs or contracts with registered\nprofessional nurses to execute the non-patient specific order and protocol, provided that the registered professional nurse(s) execute the non-patient\nspecific order and protocol only in the course of such employment or pursuant\nto such contract and provided further that the entity that is legally\nauthorized to employ or contract with registered professional to provide\nnursing services. (ii)\n\nThe written protocol, incorporated into the order prescribed in subparagraph\n(i) of this paragraph, shall, at a minimum, require the registered professional\nnurse(s) to ensure that: (a) each potential\nrecipient is assessed, pursuant to criteria in the protocol, for conditions\nthat would qualify or preclude him or her from receiving the ordered\ntuberculosis tests; (b) informed\nconsent for administering the ordered tuberculosis tests or disclosing the\ntuberculosis tests results to a third party (if applicable) has been obtained\npursuant to the criteria in the protocol from the recipient, or when the\nrecipient lacks capacity to consent, a person authorized pursuant to law to\nconsent to health care for the recipient; (c) any tuberculosis test results are\ndisclosed and any recommendations for follow up care are made in accordance\nwith the criteria in the protocol; and\n(d) the administration of the ordered\ntuberculosis tests and the test results are documented in the recipient's\nmedical record in accordance with the criteria in the protocol and that\ndocumentation relating to tuberculosis testing is maintained in accordance with\nsection\n29.2\n(a)(3)\nof this\n\nTitle; (e) additional requirements\nfor tuberculin skin tests. If the non-patient specific order authorizes a\ntuberculin skin tests, the written protocol shall, in addition to the\nforegoing: (1)\nrequire the registered\nprofessional nurse to have emergency anaphylaxis treatment agents available at\nthe tuberculin skin testing site, except in an emergency determined by the\n\nCommissioner of Health, New York City Commissioner of the Department of Health\nand Mental Hygiene, a county commissioner of health, or a county public health\ndirector; (2)\nrequire that, prior\nto administering the tuberculin skin tests, the potential test recipient or a\nperson authorized pursuant to law to consent to health care for the recipient\nreceives written information regarding the potential side effects and/or\nadverse reactions to the tuberculin skin tests and the appropriate course of\naction in the event of an adverse reaction to the test; (3)\nrequire that, prior to administering the\ntuberculin skin tests, the potential test recipient or his or her authorized\nrepresentative is informed of the need for a test evaluation within 48 to 72\nhours after the test is administered; (4)\nrequire that the test recipient or\nrecipient's authorized representative receives a signed certificate of\ntuberculin skin testing, which shall include the results with the recipient's\nname, date of tests, address where the tests was administered, administering\nnurse, manufacturer and lot numbers for the tuberculin solution administered, as well as any recommendations for future tests; and\n(5)\nrequire that the name of the manufacturer\nand lot number of the tuberculin solution that was administered to the\nrecipient are documented in his or her medical record, along with the date that\nthe tuberculin skin tests was administered and the date that the test results\nwere evaluated. (d) Human Immunodeficiency Virus (HIV) tests. (1)\n\nAs used in this subdivision, human immunodeficiency virus (HIV) test\nmeans HIV-related test\nas defined in section\n63.1\nof this Title. (2)\n\nPursuant to section 6909(5) of the\n\nEducation Law, a registered professional nurse shall be authorized to execute\nan order to administer HIV tests, pursuant to a non-patient specific order and\nprotocol prescribed and ordered by a licensed physician or a certified nurse\npractitioner, provided the order and protocol meet the requirements of\nparagraph (3) of this subdivision. The following provisions apply to the\nadministration of an HIV test pursuant to a non-patient specific standing order\nwhen such test is administered by a registered professional nurse. (3)\n\nOrder and protocol. (i) The registered professional nurse shall\neither maintain or ensure the maintenance of a copy of the non-patient specific\norder and protocol prescribed by a licensed physician or a certified nurse\npractitioner, which authorizes a registered professional nurse to execute the\norder to administer an HIV test, in accordance with the requirements of\nparagraph (2) of this subdivision. The order prescribed in subparagraph (ii) of\nthis paragraph shall incorporate a protocol that meets the requirements of\nsubparagraph (iii) of this paragraph. Such order and protocol shall be\nconsidered a record of the patient who has received an HIV test and be\nmaintained as a record for the period of time prescribed in section\n29.2\n(a)(3)\nof this\n\nTitle. (ii)\n\nThe order shall\nauthorize one or more named registered professional nurses, or registered\nprofessional nurses who are not individually named but are identified as\nemployed or under contract with an entity that is legally authorized to employ\nor contract with registered professional nurses to provide nursing services, to\nexecute the order to administer HIV tests for a prescribed period of time. In\ninstances in which the registered professional nurses are not individually\nnamed in the order, but are identified as employed or under contract with an\nentity that is legally authorized to employ or contract with registered\nprofessional nurses to provide nursing services, such registered professional\nnurses shall not be authorized by such order to execute the order to administer\nHIV tests outside of such employment or contract. The order shall contain but\nshall not be limited to the following information: (a) identification of the HIV test; (b) the period of time that the order is\neffective, including the beginning and ending dates; (c) the name and license number of the\nregistered professional nurse(s) authorized to execute the order to administer\nthe HIV test; or the name of the entity that is legally authorized to employ or\ncontract with registered professional nurses to provide nursing services with\nwhom registered professional nurses who are not individually named are employed\nor under contract to execute the order to administer the HIV test; (d) in instances in which registered\nprofessional nurses are not individually named in the order, but are identified\nas employed or under contract with an entity that is legally authorized to\nemploy or contract with registered professional nurses to provide nursing\nservices, the order shall contain a statement limiting registered professional\nnurses to execute the order to administer HIV tests only in the course of such\nemployment or pursuant to such contract; and\n(e) the name, license number, and signature\nof the licensed physician or certified nurse practitioner that has issued the\norder. (iii)\n\nThe\nprotocol, incorporated into the order prescribed in subparagraph (ii) of this\nparagraph, shall require the registered professional nurse to meet the\nfollowing requirements: (a) the registered\nprofessional nurse shall ensure that each potential recipient is assessed for\nconditions that would preclude HIV testing and ensure that each recipient's\nrecord of the HIV test with manufacturer and lot number or a potential\nrecipient's refusal to be tested is documented in accordance with section\n29.2\n(a)(3)\nof this\n\nTitle; (b) the registered\nprofessional nurse shall execute the order to administer an HIV test in\naccordance with applicable State laws and regulations, including but not\nlimited to, article 27-F of the Public Health Law and 10 NYCRR Part\n63; (c) the registered professional\nnurse shall certify that he/she obtained the written, informed consent of the\nrecipient, or when the recipient lacks capacity to consent, a person authorized\npursuant to law to consent to health care for such individual, prior to\nordering the performance of the HIV test. Informed consent shall include\npre-test counseling to the recipient, or if the recipient lacks capacity to\nconsent, a person authorized pursuant to law to consent to health care for such\nindividual. The written informed consent and the pre-test counseling shall be\nobtained and conducted in accordance with article 27-F of the Public Health Law\nand 10 NYCRR Part\n63; (d) a\nphysician or nurse practitioner who issues a non-patient specific order for HIV\ntesting shall retain responsibility for communication of a confirmatory, positive HIV test result to the recipient, or when the recipient lacks capacity\nto consent, a person authorized pursuant to law to consent to health care for\nsuch individual. A registered professional nurse is not authorized to deliver a\nfinal confirmatory HIV positive test result through a non-patient specific\norder. A registered professional nurse may only deliver a confirmatory, positive HIV test result through a patient specific order as directed by the\ntreating physician or nurse practitioner; (e) the registered professional nurse shall, upon request, ensure that the recipient, or when the recipient lacks capacity\nto consent, a person authorized pursuant to law to consent to health care for\nsuch individual, is provided with a signed certificate of HIV testing and\nresults, with the recipient's name, date of the test, address where the test\nwas administered, the name of the administering nurse, manufacturer and product\nlot number; (f) with the consent of\nthe recipient or when the recipient lacks capacity to consent, a person\nauthorized pursuant to law to consent to health care for such individual, and\nwith an appropriate authorization for the release of confidential HIV\ninformation, the registered professional nurse shall ensure that this\ninformation is communicated to the recipient's primary health care provider if\none exists in accordance with the requirements of article 27-F of the Public\n\nHealth Law and 10 NYCRR Part\n63; and\n(g) each registered professional nurse shall\nensure that a record of all persons so tested including the recipient's name, date of the test, address where the test was administered, administering nurse, test results, manufacturer, lot numbers and such other information as may be\nnecessary pursuant to the protocol is recorded and maintained in accordance\nwith section\n29.2\n(a)(3)\nof this\n\nTitle and article 27-F of the Public Health Law and 10 NYCRR Part\n63. (e) Opioid related overdose treatment. (1)\n\nAs used in this subdivision, opioid\nrelated overdose treatment shall include the administration of naloxone or\nanother drug approved by the Federal Food and Drug Administration to treat\nopioid related overdose. (2)\nA\nregistered professional nurse may administer opioid related overdose treatment\nfor the urgent or emergency treatment of opioid related overdose or suspected\nopioid related overdose pursuant to a written non-patient specific order and\nprotocol prescribed or ordered by a licensed physician or a certified nurse\npractitioner, provided that the requirements of this subdivision are\nmet. (3)\n\nOrder and protocol. (i) The non-patient specific order shall\ninclude, at a minimum, the following: (a) the\nname, license number and signature of the licensed physician or certified nurse\npractitioner who orders or prescribes the non-patient specific order and\nprotocol; (b) the name, dose and\nroute of administration of the drug to be administered to treat opioid related\noverdose; (c) a protocol for\nadministering the ordered opioid related overdose treatment or a specific\nreference to a separate written protocol for administering the ordered opioid\nrelated overdose treatment, which shall meet the requirements of subparagraph\n(ii) of this paragraph; (d) the\nperiod of time that the order is effective, including the beginning and ending\ndates; (e) a description of the\ngroup(s) of persons to be treated; and\n(f) the name and license number of the\nregistered professional nurse(s) authorized to execute the non-patient specific\norder and protocol to administer the opioid related overdose treatment; or the\nname of the entity that employs or contracts with registered professional\nnurses to execute the non-patient specific order and protocol, provided that\nthe registered professional nurses execute the non-patient specific order and\nprotocol only in the course of such employment or pursuant to such contract and\nprovided further that the entity is legally authorized to employ or contract\nwith registered professional nurses to provide nursing\nservices. (ii)\n\nThe\nwritten protocol, incorporated into the order prescribed in subparagraph (i) of\nthis paragraph, shall, at a minimum, include instructions for administering the\nopioid related overdose treatment and require the registered professional nurse\nto ensure that: (a) each potential recipient\nis assessed, pursuant to criteria in the protocol, for conditions that would\nqualify or preclude him or her from receiving the ordered opioid related\noverdose treatment; (b) consent to\nadminister treatment is obtained, pursuant to criteria in the protocol, if the\npotential recipient is capable of providing it; (c) the opioid related overdose treatment is\ndocumented, pursuant to criteria in the protocol, and includes the name and\ndose of drug administered, the date, time and location of the treatment, the\nrecipient's name and the administering registered professional nurse's name and\nthis medical documentation relating to opioid related overdose treatment is\nmaintained in accordance with paragraph 29.2(a)(3) of this Title; and\n(d) when opioid related overdose treatment is\nadministered outside of a general hospital, the recipient of the treatment is\ntransferred to a hospital for follow-up care to the extent possible along with\ndocumentation describing the opioid related overdose treatment that was\nadministered, in accordance with criteria in the\nprotocol. (f) Hepatitis C tests. (1)\n\nAs used in this subdivision, hepatitis C tests\nmean one or more laboratory or point of care\ntests approved by the Federal Food and Drug Administration to detect the\npresence of antibodies or antigens to hepatitis C or the hepatitis C\nvirus. (2)\nA registered\nprofessional nurse may administer hepatitis C tests pursuant to a written\nnon-patient specific order and protocol prescribed or ordered by a licensed\nphysician or a certified nurse practitioner, provided that the requirements of\nthis subdivision are met. (3)\n\nOrder\nand protocol. (i) The non-patient specific\norder shall include, at a minimum, the following: (a) the name, license number and signature of\nthe licensed physician or certified nurse practitioner who orders or prescribes\nthe non-patient specific order and protocol; (b) the name of the specific hepatitis C\ntests to be administered; (c) a\nprotocol for administering the ordered hepatitis C tests or a specific\nreference to a separate written protocol for administering the ordered\nhepatitis C tests, which shall meet the requirements of subparagraph (ii) of\nthis paragraph; (d) the period of\ntime that the order is effective, including the beginning and ending\ndates; (e) a description of the\ngroup(s) of persons to be tested; and\n(f) the name and license number of the\nregistered professional nurse(s) authorized to execute the non-patient specific\norder and protocol to administer the hepatitis C tests; or the name of the\nentity that employs or contracts with registered professional nurses to execute\nthe non-patient specific order and protocol, provided that the registered\nprofessional nurses execute the non-patient specific order and protocol only in\nthe course of such employment or pursuant to such contract and provided further\nthat the entity is legally authorized to employ or contract with registered\nprofessional nurses to provide nursing services. (ii)\n\nThe written protocol, incorporated into\nthe order prescribed in subparagraph (i) of this paragraph, shall, at a\nminimum, require the registered professional nurse(s) to ensure that: (a) each potential recipient is assessed, pursuant to criteria in the protocol, for conditions that would qualify or\npreclude him or her from receiving the ordered hepatitis C tests; (b) informed consent for administering the\nordered hepatitis C tests or disclosing the hepatitis C test results to a third\nparty (if applicable) has been obtained pursuant to the criteria in the\nprotocol from the recipient, or when the recipient lacks capacity to consent, a\nperson authorized pursuant to law to consent to health care for the\nrecipient; (c) confirmatory, positive hepatitis C test results are not disclosed to the test recipient or\nthe recipient's authorized representative by the registered professional nurse\nwithout a patient specific order from a licensed physician, licensed physician\nassistant or certified nurse practitioner; and\n(d) the administration of the ordered\nhepatitis C test(s) is documented in the recipient's medical record in\naccordance with criteria in the protocol and that documentation relating to the\nhepatitis C testing is maintained in accordance with section\n29.2\n(a)(3)\nof this\n\nTitle. (g) Screening for syphilis, gonorrhea and/or\nchlamydia infections. (1)\n\nAs used in this\nsubdivision, screening\nmeans an assessment of an individual to\nascertain his or her risk of having a syphilis, gonorrhea and/or chlamydia\ninfection and may include the administration of one or more laboratory or point\nof care tests approved by the Federal Food and Drug Administration to detect or\nscreen for syphilis, gonorrhea and/or chlamydia infections. (2)\nA registered professional nurse may\nscreen persons at increased risk for syphilis, gonorrhea and/or chlamydia\npursuant to a written non-patient specific order and protocol prescribed or\nordered by a licensed physician or a certified nurse practitioner, provided\nthat the requirements of this subdivision are met. (3)\n\nOrder and protocol. (i) The non-patient specific order shall\ninclude, at a minimum, the following: (a) the\nname, license number and signature of the licensed physician or certified nurse\npractitioner who orders or prescribes the non-patient specific order and\nprotocol; (b) the name of the\nspecific laboratory or point of care test(s) or assessment procedures to be\nadministered; (c) a protocol for\nadministering the ordered screening for syphilis, gonorrhea and/or chlamydia\ninfections or a specific reference to a separate written protocol for\nadministering the ordered screening for syphilis, gonorrhea and/or chlamydia, which shall meet the requirements of subparagraph (ii) of this\nparagraph; (d) the period of time\nthat the order is effective, including the beginning and ending\ndates; (e) a description of the\ngroup(s) of persons to be screened; and\n(f) the name and license number of the\nregistered professional nurse(s) authorized to execute the non-patient specific\norder and protocol to screen for syphilis, gonorrhea and/or chlamydia\ninfections; or the name of the entity that employs or contracts with registered\nprofessional nurses to execute the non-patient specific order and protocol, provided that the registered professional nurses execute the non-patient\nspecific order and protocol only in the course of such employment or pursuant\nto such contract and provided further that the entity is legally authorized to\nemploy or contract with registered professional nurses to provide nursing\nservices. (ii)\n\nThe\nwritten protocol, incorporated into the order prescribed in subparagraph (i) of\nthis paragraph, shall, at a minimum, include instructions for screening for\nsyphilis, gonorrhea and/or chlamydia infections and require the registered\nprofessional nurse(s) to ensure that: (a) each potential recipient is assessed, pursuant to criteria in the protocol, for\nconditions that would qualify or preclude him or her from receiving the ordered\nscreening tests for syphilis, gonorrhea and/or chlamydia infections; (b) informed consent for administering the\nordered screening for syphilis, gonorrhea and/or chlamydia has been obtained\nfrom the recipient pursuant to the criteria in the protocol, or when the\nrecipient lacks capacity to consent, from a person authorized pursuant to law\nto consent to health care for the recipient; (c) positive test results for syphilis, gonorrhea and/or chlamydia infections are not disclosed to the test recipient\nor the recipient's authorized representative by the registered professional\nnurse without a patient specific order from a licensed physician, licensed\nphysician assistant or certified nurse practitioner; and\n(d) the administration of the ordered\nscreening for syphilis, gonorrhea and/or chlamydia is documented in the\nrecipient's medical record in accordance with criteria in the protocol and that\ndocumentation relating to the screening for syphilis, gonorrhea and/or\nchlamydia is maintained in accordance with section\n29.2\n(a)(3)\nof this\n\nTitle. (h) COVID-19 tests and influenza tests. (1)\n\nAs used in this subdivision: (i) COVID-19 test means one or more\nlaboratory or point of care tests that have been fully approved or have\nreceived emergency use authorization by the Federal Food and Drug\n\nAdministration to detect COVID-19 or its antibodies or to detect COVID-19 and\ninfluenza virus; and\n(ii)\ninfluenza\ntest means one or more laboratory or point of care tests approved by the\n\nFederal Food and Drug Administration to detect influenza virus. (2)\nA registered professional\nnurse may administer a COVID-19 test or an influenza test pursuant to a written\nnon-patient specific order and protocol prescribed or ordered by a licensed\nphysician or a certified nurse practitioner, provided that the requirements of\nthis subdivision are met. (3)\n\nOrder\nand protocol. (i) The non-patient specific\norder shall include, at a minimum, the following: (a) the name, license number and signature of\nthe licensed physician or certified nurse practitioner who orders or prescribes\nthe nonpatient specific order and protocol; (b) the name of the specific COVID-19 or\ninfluenza test to be administered; (c) a protocol for administering the ordered\nCOVID-19 or influenza test or a specific reference to a separate written\nprotocol for administering the ordered test, which shall meet the requirements\nof subparagraph (ii) of this paragraph; (d) the period of time that the order is\neffective, including the beginning and ending dates; (e) a description of the group(s) of persons\nto be tested; and\n(f) the name and\nlicense number of the registered professional nurse(s) authorized to execute\nthe non-patient specific order and protocol to administer the ordered COVID-19\nor influenza test, or the name of the entity that employs or contracts with\nregistered professional nurse(s) to execute the non-patient specific order and\nprotocol, provided that the registered professional nurse(s) execute the\nnon-patient specific order and protocol only in the course of such employment\nor pursuant to such contract and the entity is legally authorized to employ or\ncontract with registered professional nurses to provide nursing\nservices. (ii)\n\nThe\nwritten protocol, incorporated into the order prescribed in subparagraph (i) of\nthis paragraph, shall, at a minimum, require the registered professional\nnurse(s) to ensure that: (a) each potential\nrecipient is assessed, pursuant to criteria in the protocol, for conditions\nthat would qualify or preclude him or her from receiving the ordered\ntest; (b) informed consent for\nadministering the ordered test or disclosing the test results to a third party\n(if applicable) has been obtained pursuant to the criteria in the protocol from\nthe recipient, or when the recipient lacks capacity to consent, a person\nauthorized pursuant to law to consent to health care for the\nrecipient; (c) positive diagnostic\ntest results shall be disclosed to the test recipient, or the recipient's\nauthorized representative, by the registered professional nurse as specifically\nauthorized by the protocol or pursuant to a patient specific order from a\nlicensed physician, licensed physician assistant, or certified nurse\npractitioner; and\n(d) the\nadministration of the ordered test(s) is documented in the recipient's medical\nrecord in accordance with criteria in the protocol. Such documentation shall be\nmaintained in accordance with section\n29.2\n(a)(3)\nof this\n\nTitle. (i) Emergency medical care. (1)\n\nAs used in this subdivision: (i) Hospital means a general hospital as\ndefined in subdivision 10 of section\n2801\nof the\npublic health law. (ii)\n\nStanding\norder means a written non-patient specific order and protocol prescribed or\nordered by a licensed physician or certified nurse practitioner for providing\nemergency medical care to patients. (iii)\n\nPatient means a person receiving\nmedical care in a hospital or from another health care provider. (v) Emergency medical care means medical care\nthat is ordered or prescribed to expedite the detection of signs and symptoms\nof certain emergency medical conditions in patients or expedite medical\nintervention for emergency medical conditions or suspected emergency medical\nconditions. Such emergency medical care includes: (a) administering an electrocardiogram to\ndetect electrocardiographic changes and/or arrythmias associated with acute\ncoronary syndrome, as set forth in a standing order; (b) administering point-of-care tests that\nare approved by the United States Food and Drug Administration to determine\nblood glucose levels in patients with suspected hypoglycemia for the purpose of\nevaluating acute mental status changes, as set forth in a standing\norder; (c) administering tests, which may include laboratory or point-of-care tests that are approved by the\n\nUnited States Food and Drug Administration or the department of health, to\npatients who meet criteria for severe sepsis and septic shock as set forth in a\nstanding order; and\n(d) establishing peripheral venous access on patients who meet severe sepsis and\nseptic shock criteria as set forth in a standing order. (2)\nA registered professional\nnurse may provide emergency medical care pursuant to a standing order, provided\nthat the requirements of this subdivision are met. The registered professional\nnurse shall: (i) be certified in\ncardio-pulmonary resuscitation, basic life support or more advanced life\nsupport by the American Red Cross, the American Heart Association, or an\nequivalent organization, acceptable to the department, which provides\ncardio-pulmonary resuscitation or life support training programs; or\n(ii)\nbe trained in or credentialed in basic\nor more advanced life support in a hospital if the registered professional\nnurse works in the hospital. (3)\n\nStanding order. (i) The standing order shall include, at a\nminimum: (a) the name, license number and\nsignature of the licensed physician or certified nurse practitioner who orders\nor prescribes the standing order; (b) the name of the medical condition(s) for\nwhich the emergency medical care is ordered or prescribed to screen\nfor; (c) the name of the specific\nlaboratory or point of care test(s), other medical test(s), or medical\nprocedure(s) to be performed; (d) a\nprotocol for providing the ordered emergency medical care or a specific\nreference to a separate written protocol for providing the ordered emergency\nmedical care, which shall meet the requirements of subparagraph (ii) of this\nparagraph; (e) the period of time\nthat the order is effective, including the beginning and ending\ndates; (f) a description of the\ngroup(s) of patients or persons who may receive the ordered emergency medical\ncare; and\n(g) the name and license\nnumber of the registered professional nurse(s) authorized to execute the\nstanding order or the name of the entity that employs or contracts with\nregistered professional nurses to execute the standing order, provided that the\nregistered professional nurses execute the standing order only in the course of\nsuch employment or pursuant to such contract and provided further that the\nentity is legally authorized to employ or contract with registered professional\nnurses to provide nursing services. (ii)\n\nThe written protocol, incorporated into\nthe standing order prescribed in subparagraph (i) of this paragraph, shall, at\na minimum, ensure that: (a) each potential\nrecipient of ordered emergency medical care is assessed, pursuant to measurable\ncriteria in the protocol, for conditions that would qualify or preclude them\nfrom receiving the ordered emergency medical care; (b) consent to provide the ordered emergency\nmedical care pursuant to criteria in the protocol if the potential recipient is\ncapable of providing it or from a person authorized by law to consent to health\ncare on behalf of the potential recipient, if immediately available; (c) instructions necessary for providing the\nordered emergency medical care; (d) any follow up actions to be undertaken by the registered professional nurse are\ndescribed, including, but not limited to, disclosing test results to a third\nparty or the recipient of the ordered test; (e) when ordered emergency medical care is\nprovided outside of a hospital, the recipient of the medical care is\ntransferred to a general hospital for follow-up care in accordance with\ncriteria in the protocol; and\n(f) the provision of the ordered emergency medical care is documented in the\npatient's medical record and the documentation relating to the ordered\nemergency medical care is maintained in accordance with section\n29.2\n(a)(3)\nof this\n\nTitle. (iii)\n\nNothing in\nthis subdivision shall construed to authorize a registered professional nurse\nto determine or rule out any medical diagnosis or determine any medical\ntreatment to be provided. (iv)\n\nNothing in this subdivision shall be construed to delay access to medical\nservices to be provided by a licensed physician, or emergency transportation to\na hospital. (j) Pregnancy tests. (1)\n\nAs used in this\nsubdivision, pregnancy test means a laboratory or point-of-care test that is\napproved by the United States Food and Drug Administration to determine\npregnancy. (2)\nA registered\nprofessional nurse may administer a pregnancy test pursuant to a non-patient\nspecific order and protocol prescribed or ordered by a licensed physician or a\ncertified nurse practitioner, provided that the requirements of this\nsubdivision are met. (3)\n\nOrder and\nprotocol. (i) The order shall include, at a\nminimum: (a) the name, license number and\nsignature of the licensed physician or certified nurse practitioner who orders\nor prescribes the nonpatient specific order and protocol; (b) the name of the specific pregnancy test\nto be administered; (c) a protocol\nfor administering the ordered pregnancy test or a specific reference to a\nseparate written protocol administering the ordered pregnancy test, which shall\nmeet the requirements of subparagraph (ii) of this paragraph; (d) the period of time that the order is\neffective, including the beginning and ending dates; (e) a description of the group(s) of persons\nto be tested; and\n(f) the name and\nlicense number of the registered professional nurse(s) authorized to execute\nthe non-patient specific order and protocol to administer the pregnancy test, or the name of the entity that employs or contracts with registered\nprofessional nurses to execute the non-patient specific order and protocol only\nin the course of such employment or pursuant to such contract and provided\nfurther that the entity is legally authorized to employ or contract with\nregistered professional nurses to provide nursing services. (ii)\n\nThe written protocol, incorporated into the order prescribed in subparagraph (i) of this paragraph, shall, at a minimum, ensure that: (a) each\npotential recipient is screened, pursuant to criteria in the protocol, for\nconditions that would qualify or preclude them from receiving the ordered\npregnancy test; (b) informed\nconsent for administering the ordered pregnancy test or disclosing the test\nresults to a third party (if applicable) has been obtained pursuant to criteria\nin the protocol from the recipient or when the recipient lacks capacity to\nconsent, a person authorized by law to consent to health care for the\nrecipient; (c) any follow up\nactions to be undertaken by the registered professional nurse are described, including, but not limited to, disclosing test results to a third party or the\nrecipient of the ordered test; and\n(d) the administration of the ordered\npregnancy tests is documented in the recipient's medical record in accordance\nwith criteria in the protocol, and that documentation relating to the pregnancy\ntest is maintained in accordance with section\n29.2\n(a)(3)\nof this\n\nTitle. Notes\nN.Y. Comp. Codes R. & Regs. Tit. 8\nยง\n64.7\n\nAmended\n\nNew\n\nYork State Register October 7, 2015/Volume XXXVII, Issue 40, eff. 10/7/2015\n\nAmended\n\nNew\n\nYork State Register June 1, 2016/Volume XXXVIII, Issue 22, eff. 6/1/2016\n\nAmended\n\nNew\n\nYork State Register June 28, 2017 /Volume XXXIX, Issue 26, eff. 6/28/2017\n\nAmended\n\nNew\n\nYork State Register September 25, 2019/Volume XLI, Issue 39, eff. 9/25/2019\n\nAmended\n\nNew\n\nYork State Register March 2, 2022/Volume XLIV, Issue 09, eff. 3/2/2022\n\nAmended\n\nNew\n\nYork State Register January 25, 2023/Volume XLIV, Issue 04, eff. 1/25/2023\n\nAmended\n\nNew\n\nYork State Register February 28, 2024/Volume XLVI, Issue 9, eff. 2/28/2024\n\nAmended\n\nNew\n\nYork State Register March 27, 2024/Volume XLVI, Issue 13, eff. 3/11/2024, exp. 5/9/2024\n(Emergency)\n\nAmended\n\nNew\n\nYork State Register May 1, 2024/Volume XLVI, Issue 18, eff. 5/1/2024\n\nAmended\n\nNew\n\nYork State Register May 28, 2025/Volume XLVII, Issue 21, eff. 5/12/2025, exp. 7/10/2025\n(Emergency)\n\nThe amended version of this section by\n\nNew\n\nYork State Register May 28, 2025/Volume XLVII, Issue 21, eff. 5/12/2025\nis not yet\navailable. The Amended version of this section by\n\nNew\n\nYork State Register June 25, 2025/Volume XLVII, Issue 25, eff. 6/25/2025\nis not yet\navailable. State regulations are updated quarterly; we currently have two versions available. Below is a\ncomparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare. No prior version found.",
  "url_type": "unknown",
  "source_index": 24310
}